Ultragenyx Pharmaceutical
RARE
#5301
Rank
โ‚น153.93 B
Marketcap
โ‚น1,510
Share price
-1.17%
Change (1 day)
-47.64%
Change (1 year)

EPS for Ultragenyx Pharmaceutical (RARE)

EPS in 2026 (TTM): -โ‚น484.52

According to Ultragenyx Pharmaceutical's latest financial reports the company's current EPS (TTM) is -โ‚น487.46. In 2025 the company made an earnings per share (EPS) of -โ‚น548.51 an increase over its 2024 EPS that were of -โ‚น595.47.

EPS history for Ultragenyx Pharmaceutical from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น484.52-11.67%
2025-โ‚น548.51-7.89%
2024-โ‚น595.47-23.89%
2023-โ‚น782.37-17.61%
2022-โ‚น949.5650.67%
2021-โ‚น630.22113.69%
2020-โ‚น294.92-55.9%
2019-โ‚น668.7382.56%
2018-โ‚น366.30-45.15%
2017-โ‚น667.7914.68%
2016-โ‚น582.32
2014-โ‚น217.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Lexicon Pharmaceuticals
LXRX
-โ‚น13.15-97.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น1.88-99.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-โ‚น10.33-97.88%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-โ‚น8.45-98.27%๐Ÿ‡บ๐Ÿ‡ธ USA